Skip to main content

Table 1 Precision of endpoint estimates

From: The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens

Endpoint Proportion 95% CI
0 [0, 0.0015]a
0.05 [0.04, 0.06]
0.10 [0.09, 0.11]
0.20 [0.18, 0.22]
0.30 [0.28, 0.32]
0.40 [0.38, 0.42]
0.50 [0.48, 0.52]
0.60 [0.58, 0.62]
0.70 [0.68, 0.72]
0.80 [0.78, 0.82]
0.90 [0.89, 0.91]
  1. aExact 95 CI